| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 25,920 | 27,402 | 27,775 | 30,240 | | Cost of Revenue | 6,581 | 6,910 | 7,125 | 7,902 | | | Gross Profit | 19,339 | 20,492 | 20,650 | 22,338 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,850 | 16,133 | 13,899 | 13,565 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 21,560 | 20,186 | 4,087 | 3,052 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (18,071) | (15,827) | 2,664 | 5,721 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (18,071) | (15,827) | 2,664 | 5,721 | | Interest Expense | 1,977 | 2,005 | 2,017 | 2,393 | | Income Before Tax | (20,048) | (17,832) | 647 | 3,328 | | Income Tax Expense | (3,147) | (6,975) | 211 | (495) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (16,901) | (10,857) | 436 | 3,823 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (16,901) | (10,857) | 436 | 3,823 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($16,901) | ($10,857) | $436 | $3,823 |
|
0.49% Nasdaq 
Income Statement
